NCT07200687

Brief Summary

This study aims to explore the effects of an occupational therapy program combined with music therapy elements on children 5-12 years old with neurological disorders including those with neurogenic scoliosis. Occupational therapy programs typically focus on improving motor and cognitive functions to enhance the child's overall participation and daily functioning. Music has been shown to positively affect brain areas involved in emotions, memory, and language, and may reduce stress and increase feelings of happiness. The study will measure changes in biological markers such as blood pressure, oxygen saturation, heart rate, and respiratory rate, as well as improvements in functionality for upper limbs but also balance and walking ability after the therapy program. These markers can provide valuable information about the physical health and quality of life of the children, which is currently lacking for the Greek population. By investigating these biological indicators along with functional outcomes, this research hopes to offer new insights into the benefits of combining music therapy with occupational therapy. This may encourage better engagement from families and support rehabilitation specialists in demonstrating the value of their interventions even before functional improvements become noticeable

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

October 7, 2025

Status Verified

October 1, 2025

Enrollment Period

3 months

First QC Date

September 11, 2025

Last Update Submit

October 1, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • 10M WALK TEST

    WALKING ABILITY

    From enrollment to the end of treatment at 6weeks

  • pediatric balance scale

    balance Pediatric Balance Scale (PBS) is used, specifically the Greek validated version ("Pediatric Balance Scale - Greek version," PBS-GR), as translated and cross-culturally adapted by Bania et al. (2023). The scale ranges from 0 to 56, with higher scores indicating better balance performance and a better outcome. The PBS-GR has been shown to have high interrater reliability in children with movement impairment

    "From enrollment to the end of treatment at 6 weeks"

Secondary Outcomes (4)

  • blood pressure

    Arterial blood pressure will be measured using an automated electronic sphygmomanometer (mmHg). Measurements will be taken in a seated position after 5 minutes of rest, immediately before and immediately after (45 min) each therapy session.

  • SaO2 oxygen saturation

    Oxygen saturation will be measured non-invasively using a fingertip pulse oximeter (%). Measurements will be taken in a seated position, after 5 minutes of rest, immediately before and immediately after each (45 min) therapy session.

  • heart rate

    Heart rate will be measured non-invasively using an electronic sphygmomanometer (beats per minute, bpm). Measurements will be taken in a seated position, after 5 minutes of rest, immediately before and immediately after (45 min)each therapy session

  • Respiratory Rate

    Respiratory rate will be measured manually by counting visible thoracic movements (breaths per minute) for 60 seconds while the child is in a seated position before and after (45 min) each therapy session

Study Arms (3)

Occupational Therapy + Music Therapy (with scoliosis)

EXPERIMENTAL

This arm includes children with neurological conditions and scoliosis who will receive a structured occupational therapy program incorporating music therapy elements

Other: Music therapyOther: occupational therapy

Occupational Therapy

ACTIVE COMPARATOR

This group includes children with similar neurological conditions and scoliosis who will receive the same occupational therapy program without any music therapy integration.

Other: occupational therapy

Occupational Therapy + Music Therapy (no scoliosis)

EXPERIMENTAL

Children with neurological conditions but without scoliosis receive the same occupational therapy program combined with music therapy. This arm allows the evaluation of music therapy's effects in children with neurological conditions independent of spinal deformity

Other: Music therapyOther: occupational therapy

Interventions

this research hopes to offer new insights into the benefits of combining music therapy with occupational therapy.

Occupational Therapy + Music Therapy (no scoliosis)Occupational Therapy + Music Therapy (with scoliosis)

standard treatment

Occupational TherapyOccupational Therapy + Music Therapy (no scoliosis)Occupational Therapy + Music Therapy (with scoliosis)

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of a neurological condition with established neurological signs (e.g., motor or cognitive impairments)
  • Cerebral Palsy (GMFCS levels I-II),
  • Brain infections (e.g., encephalitis),
  • Brain neoplasms
  • Ability to follow simple instructions and participate in an occupational therapy program,
  • Medical clearance to participate in physical activity

You may not qualify if:

  • Degenerative neurological diseases,
  • Metabolic disorders affecting the nervous system,
  • Neuromuscular disorders, including muscular dystrophy and congenital myopathies,
  • Peripheral nervous system damage,
  • Current use of corticosteroids,
  • Botulinum toxin injection within 30 days prior to the intervention program,
  • Hearing loss or diagnosed deafness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Athens Children's Hospital P.&A. Kiriakou

Athens, Attica, Greece

Location

MeSH Terms

Conditions

Cerebral PalsyEncephalitisBrain Neoplasms

Interventions

Music TherapyOccupational Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeuroinflammatory DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, MSc, PhDc

Study Record Dates

First Submitted

September 11, 2025

First Posted

October 1, 2025

Study Start

July 1, 2025

Primary Completion

September 30, 2025

Study Completion

October 1, 2025

Last Updated

October 7, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations